Sophie R. Cohen

Functional genomics of psychiatric disease risk using genome engineering

K. Brennand, S. Akbarian, G. Fang, 2021, Epigenetics in Psychiatry.

Characterizing the relationship between L-DOPA-induced-dyskinesia and psychosis-like behaviors in a bilateral rat model of Parkinson's disease

F. Manfredsson, C. Bishop, Ashley Centner, 2023, Neurobiology of Disease.

Broad Serotonergic Actions of Vortioxetine as a Promising Avenue for the Treatment of L-DOPA-Induced Dyskinesia

F. Manfredsson, Michael Coyle, C. Bishop, 2023, Cells.

The effects of Vilazodone, YL-0919 and Vortioxetine in hemiparkinsonian rats

Michael Coyle, C. Bishop, Ashley Centner, 2022, Psychopharmacology.

The multimodal serotonin compound Vilazodone alone, but not combined with the glutamate antagonist Amantadine, reduces l-DOPA-induced dyskinesia in hemiparkinsonian rats

F. Manfredsson, Michael Coyle, C. Bishop, 2022, Pharmacology Biochemistry and Behavior.

Deficits in basal and evoked striatal dopamine release following alpha‐synuclein preformed fibril injection: An in vivo microdialysis study

Joseph R. Patterson, C. Sortwell, Michael Kubik, 2024, The European journal of neuroscience.